These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 14499935

  • 1. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center.
    Petrucca A, Cipriani P, Valenti P, Santapaola D, Cimmino C, Scoarughi GL, Santino I, Stefani S, Sessa R, Nicoletti M.
    Res Microbiol; 2003 Sep; 154(7):491-8. PubMed ID: 14499935
    [Abstract] [Full Text] [Related]

  • 2. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
    Mahenthiralingam E, Vandamme P, Campbell ME, Henry DA, Gravelle AM, Wong LT, Davidson AG, Wilcox PG, Nakielna B, Speert DP.
    Clin Infect Dis; 2001 Nov 01; 33(9):1469-75. PubMed ID: 11588691
    [Abstract] [Full Text] [Related]

  • 3. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.
    McDowell A, Mahenthiralingam E, Moore JE, Dunbar KE, Webb AK, Dodd ME, Martin SL, Millar BC, Scott CJ, Crowe M, Elborn JS.
    J Clin Microbiol; 2001 Dec 01; 39(12):4247-55. PubMed ID: 11724828
    [Abstract] [Full Text] [Related]

  • 4. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.
    Henry DA, Mahenthiralingam E, Vandamme P, Coenye T, Speert DP.
    J Clin Microbiol; 2001 Mar 01; 39(3):1073-8. PubMed ID: 11230429
    [Abstract] [Full Text] [Related]

  • 5. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status.
    Agodi A, Mahenthiralingam E, Barchitta M, Gianninò V, Sciacca A, Stefani S.
    J Clin Microbiol; 2001 Aug 01; 39(8):2891-6. PubMed ID: 11474009
    [Abstract] [Full Text] [Related]

  • 6. Burkholderia cepacia complex: distribution of genomovars among isolates from the maize rhizosphere in Italy.
    Fiore A, Laevens S, Bevivino A, Dalmastri C, Tabacchioni S, Vandamme P, Chiarini L.
    Environ Microbiol; 2001 Feb 01; 3(2):137-43. PubMed ID: 11321544
    [Abstract] [Full Text] [Related]

  • 7. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients.
    Coenye T, LiPuma JJ, Henry D, Hoste B, Vandemeulebroecke K, Gillis M, Speert DP, Vandamme P.
    Int J Syst Evol Microbiol; 2001 Mar 01; 51(Pt 2):271-9. PubMed ID: 11321071
    [Abstract] [Full Text] [Related]

  • 8. PCR-based identification and characterization of Burkholderia cepacia complex bacteria from clinical and environmental sources.
    Seo ST, Tsuchiya K.
    Lett Appl Microbiol; 2004 Mar 01; 39(5):413-9. PubMed ID: 15482431
    [Abstract] [Full Text] [Related]

  • 9. DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III.
    Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, Vandamme P.
    J Clin Microbiol; 2000 Sep 01; 38(9):3165-73. PubMed ID: 10970351
    [Abstract] [Full Text] [Related]

  • 10. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis.
    Chen JS, Witzmann KA, Spilker T, Fink RJ, LiPuma JJ.
    J Pediatr; 2001 Nov 01; 139(5):643-9. PubMed ID: 11713440
    [Abstract] [Full Text] [Related]

  • 11. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center.
    Manno G, Dalmastri C, Tabacchioni S, Vandamme P, Lorini R, Minicucci L, Romano L, Giannattasio A, Chiarini L, Bevivino A.
    J Clin Microbiol; 2004 Apr 01; 42(4):1491-7. PubMed ID: 15070994
    [Abstract] [Full Text] [Related]

  • 12. Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production.
    Carvalho AP, Ventura GM, Pereira CB, Leão RS, Folescu TW, Higa L, Teixeira LM, Plotkowski MC, Merquior VL, Albano RM, Marques EA.
    APMIS; 2007 Apr 01; 115(4):311-8. PubMed ID: 17504297
    [Abstract] [Full Text] [Related]

  • 13. Burkholderia cepacia complex in cystic fibrosis and non-cystic fibrosis patients: identification of a cluster of epidemic lineages.
    Agodi A, Barchitta M, Gianninò V, Collura A, Pensabene T, Garlaschi ML, Pasquarella C, Luzzaro F, Sinatra F, Mahenthiralingam E, Stefani S.
    J Hosp Infect; 2002 Mar 01; 50(3):188-95. PubMed ID: 11886194
    [Abstract] [Full Text] [Related]

  • 14. Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.
    Campana S, Taccetti G, Ravenni N, Favari F, Cariani L, Sciacca A, Savoia D, Collura A, Fiscarelli E, De Intinis G, Busetti M, Cipolloni A, d'Aprile A, Provenzano E, Collebrusco I, Frontini P, Stassi G, Trancassini M, Tovagliari D, Lavitola A, Doherty CJ, Coenye T, Govan JR, Vandamme P.
    J Clin Microbiol; 2005 Oct 01; 43(10):5136-42. PubMed ID: 16207975
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of species-specific recA-based PCR tests for genomovar level identification within the Burkholderia cepacia complex.
    Vermis K, Coenye T, Mahenthiralingam E, Nelis HJ, Vandamme P.
    J Med Microbiol; 2002 Nov 01; 51(11):937-940. PubMed ID: 12448677
    [Abstract] [Full Text] [Related]

  • 16. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis.
    LiPuma JJ, Spilker T, Gill LH, Campbell PW, Liu L, Mahenthiralingam E.
    Am J Respir Crit Care Med; 2001 Jul 01; 164(1):92-6. PubMed ID: 11435245
    [Abstract] [Full Text] [Related]

  • 17. Molecular epidemiology of cystic fibrosis-linked Burkholderia cepacia complex isolates from three national referral centres in Ireland.
    Crowley D, Daly M, Lucey B, Shine P, Collins JJ, Cryan B, Moore JE, Murphy P, Buckley G, Fanning S.
    J Appl Microbiol; 2002 Jul 01; 92(5):992-1004. PubMed ID: 11972706
    [Abstract] [Full Text] [Related]

  • 18. Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand.
    Kidd TJ, Douglas JM, Bergh HA, Coulter C, Bell SC.
    Res Microbiol; 2008 Apr 01; 159(3):194-9. PubMed ID: 18356026
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of restriction fragment length polymorphism analysis of 16S rDNA as a tool for genomovar characterisation within the Burkholderia cepacia complex.
    Vermis K, Vandekerckhove C, Nelis HJ, Vandamme PA.
    FEMS Microbiol Lett; 2002 Aug 27; 214(1):1-5. PubMed ID: 12204364
    [Abstract] [Full Text] [Related]

  • 20. Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex.
    Herasimenka Y, Cescutti P, Impallomeni G, Campana S, Taccetti G, Ravenni N, Zanetti F, Rizzo R.
    J Cyst Fibros; 2007 Apr 27; 6(2):145-52. PubMed ID: 16860003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.